| 000 | 01158 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513021633.0 | ||
| 264 | 0 | _c19820826 | |
| 008 | 198208s 0 0 eng d | ||
| 022 | _a0143-3180 | ||
| 024 | 7 |
_a10.1111/j.1365-2710.1981.tb00981.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuri, P | |
| 245 | 0 | 0 |
_aComparative in vitro evaluation of six commercial vincamine prolonged-release dosage forms. _h[electronic resource] |
| 260 |
_bJournal of clinical and hospital pharmacy _cJun 1981 |
||
| 300 |
_a101-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSwitzerland |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVinca Alkaloids _xadministration & dosage |
| 650 | 0 | 4 |
_aVincamine _xadministration & dosage |
| 700 | 1 | _aDoelker, E | |
| 700 | 1 | _aBoucherat, J | |
| 773 | 0 |
_tJournal of clinical and hospital pharmacy _gvol. 6 _gno. 2 _gp. 101-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2710.1981.tb00981.x _zAvailable from publisher's website |
| 999 |
_c7343071 _d7343071 |
||